CIBC Bancorp USA’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
CIBC Bancorp USA's PCVX Position: Q3 2026 in Review
CIBC Bancorp USA increased its Vaxcyte (PCVX) stake by 35% in Q3 2026, buying an estimated $336K and bringing the position to 22,088 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1054.
CIBC Bancorp USA first reported a position in PCVX in Q3 2025 and has held it in 4 quarters since. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- CIBC Bancorp USA held 22,088 shares of Vaxcyte worth $1.26M as of Q3 2026.
- CIBC Bancorp USA bought 5,756 Vaxcyte shares in Q3 2026, an estimated $336K.
- Vaxcyte made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #1054 holding.
- CIBC Bancorp USA first reported a position in Vaxcyte in Q3 2025 and has held it in 4 quarters since.
- 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.